Dr Keith Meaney PhD

Dr Keith Meaney is Operations Director for the Kings College London Gene Therapy Vector Facility (GTVF). He holds a Ph.D in Chemistry and diploma in Biopharmaceutical Science and has extensive experience in the pharmaceutical industry over the last 20 years with companies such as BMS, GSK, Mundipharma, Johnson Matthey Health Division and prior to joining Kings worked in Development/ CMC Operations for Freeline Therapeutics a leading CGT biotech in AAV therapeutics.

He is responsible for all operations at the facility leading a multi-disciplinary team of business development, process development, business operations, quality assurance, quality control, technical and production scientists.